Results 111 to 120 of about 63,671 (294)

Proteomic study on the lymphocytes from pregnant Wistar rat females treated with immunosuppressive regimen

open access: yesClinical and Translational Science, Volume 16, Issue 1, Page 118-127, January 2023., 2023
Abstract Kidney transplantation remains the therapeutic option for patients with end‐stage kidney disease. Current immunosuppressive regimens are efficient in combating acute kidney rejection. However, insights into chronic kidney allograft injury remains limited.
Bartosz Wojciuk   +6 more
wiley   +1 more source

Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Clostridioides difficile infection (CDI) worsens the prognosis of patients with inflammatory bowel disease (IBD). This retrospective cohort study aimed to evaluate the risk factors, clinical manifestations, and outcomes of CDI in hospitalized patients with IBD, including those with toxin A/B results between April 2007 and April 2021.
Puo‐Hsien Le   +10 more
wiley   +1 more source

Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. [PDF]

open access: bronze, 1976
H Berry   +5 more
openalex   +1 more source

Further Experience with Azathioprine in Rheumatoid Arthritis [PDF]

open access: bronze, 1971
Judi Harris   +2 more
openalex   +1 more source

Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study

open access: yesMolecular Nutrition &Food Research, EarlyView.
This study investigated how pomegranate juice affects inflammation in patients with inflammatory bowel disease who are currently in remission. After 12 weeks of drinking pomegranate juice, patients showed reduced markers of intestinal inflammation.
Ilaria Minato   +25 more
wiley   +1 more source

Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal

open access: yesEuropean Journal of Neurology, Volume 30, Issue 1, Page 266-282, January 2023., 2023
Myasthenia gravis is recognized as an immunoglobulin G autoantibody‐mediated disease, but the relationship between autoantibody levels and disease activity is unclear. We conducted a systematic literature review to evaluate this landscape, which yielded 10 studies mainly describing a positive, significant correlation.
Andreas Meisel   +13 more
wiley   +1 more source

Predictive Value of Perioperative Blood Lactic Acid Levels for Postoperative Crisis in Myasthenia Gravis Patients Undergoing Thymectomy

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Postoperative myasthenic crisis (POMC), which occurs specifically after thymectomy in myasthenia gravis (MG) patients, is a serious complication with known risk factors such as prior myasthenic crisis. However, the predictive value of perioperative blood lactic acid levels (BLAL) for POMC remains unclear.
Jianyong Zou   +7 more
wiley   +1 more source

Clinical characteristics, treatments, outcome, and prognostic factors of severe autoimmune encephalitis in the intensive care unit: Standard treatment and the value of additional plasma cell–depleting escalation therapies for treatment‐refractory patients

open access: yesEuropean Journal of Neurology, Volume 30, Issue 2, Page 474-489, February 2023., 2023
Our retrospective study analyzed 40 patients with intensive care unit (ICU)‐dependent autoimmune encephalitis (AE) for clinical characteristics, diagnostics, prognostic factors, and clinical outcomes regarding standard treatment in responsive patients versus additional escalation therapies for treatment‐refractory cases.
Lisa Schwarz   +4 more
wiley   +1 more source

Clinical Case: A Patient with Weakness, Skin Rashes, Increased Transaminase Activity and Bilirubin Levels

open access: yesРоссийский журнал гастроэнтерологии, гепатологии, колопроктологии
Aim: to increase physicians’ awareness of differential diagnosis of autoimmune hepatitis and diffuse connective tissue disease using a clinical case as an example. Key points.
D. A. Davydov   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy